We used the recently described technique of singlestranded conformation-polymorphism (SSCP) analysis to examine the insulin-receptor locus. First, the ability of the method to detect known mutations and polymorphisms in the insulin-receptor coding sequence was assessed. Regions of the insulinreceptor sequence containing 16 different nucleotide changes, 9 in patient genomic DNA and 7 as cloned cDNA in plasmids, were analyzed. All 9 patient genomic DNA mutants and 5 of 7 plasmid mutants exhibited variant SSCP patterns. To investigate the potential of the technique for screening many patients, the 5 exons that encode the tyrosine kinase domain of the insulin receptor were examined in 30 unrelated white subjects with non-insulin-dependent diabetes mellitus (NIDDM). Exons 17-21 were amplified from genomic DNA with polymerase chain reaction and subjected to SSCP analysis. Exons 19, 20, and 21 revealed no bands of aberrant migration, suggesting a high degree of conservation of these sequences. One diabetic subject had an SSCP variant in exon 18. Direct sequencing of this subject's genomic DNA revealed a heterozygous missense mutation (Lys 1068 -> Glu
we detected two previously unreported amino acid substitutions in the highly conserved tyrosine kinase domain of the insulin receptor. These represent the first potentially significant mutations found by screening candidate genes in NIDDM. The detection of one of these variants in a normoglycemic subject suggests that it is unlikely to cause the diabetic state, but given the complex genetic basis for NIDDM, a possible contributory role of each of these mutations mandates further study. Diabetes 40:777-82,1991 M utations of the insulin-receptor gene have been reported, to date, in 14 patients with rare syndromes of severe insulin resistance (1) (2) (3) . In the general population, insulin resistance contributes to non-insulin-dependent diabetes mellitus (NIDDM; 4) and may be a central feature of a constellation of atherogenic metabolic variables sometimes referred to as syndrome X (5) . The role of inherited defects of the insulin receptor in these conditions is unknown. Some but not all studies of insulin-receptor restriction-fragment-length polymorphisms have suggested an association of certain haplotypes with NIDDM (6, 7) . The fact that the genetically affected relatives of some subjects with leprechaunism (8) or type A syndrome (3) demonstrate modest insulin resistance in the absence of any striking clinical features suggests that at least some insulin resistance in the general population is caused by mutations of the insulin-receptor gene.
The insulin-receptor gene is large, with 4.1 kilobases (kb) of coding sequence distributed over 22 exons. Sequencing of the entire coding sequence is therefore a laborious process, and only four subjects with NIDDM (3 Pima Indians and 1 white) have had their entire sequence determined. No differences from the previously published "normal" sequence (9, 10) were detected (11) (12) (13) .
Several so-called "molecular scanning" methods have been designed to more rapidly detect deviations from the normal nucleotide sequence in short fragments of DNA (14) , although none have yet been applied to NIDDM. The RNase A cleavage method, in particular, has been widely used but is quite labor intensive, and only -6 0 % of mismatches are detected (14) . Another approach is based on differential melting of DNA duplexes in a denaturing gradient. Even with modifications such as the addition of a "GC clamp," this method may be insensitive to mutations in certain regions (14) .
We have applied the technique of single-stranded conformation polymorphisms (SSCP) developed by Orita et al. (15) to the detection of nucleotide changes in the insulinreceptor locus. This technique involves the amplification of the DNA sequence of interest with the polymerase chain reaction (PCR) in the presence of radioactive nucleotide. The radiolabeled PCR products are denatured and subjected to electrophoresis in a nondenaturing polyacrylamide gel. Orita et al. demonstrated that single-nucleotide changes in fragments as long as 400 base pairs (bp) could cause detectable shifts in mobility, and they propose that this differential mobility is due to varying secondary structure assumed by different single strands in the gel.
We examined the potential utility of this technique in two sets of experiments. First, to assess the sensitivity and specificity of the technique, known mutations and polymorphisms (both naturally occurring and generated in vitro) were examined in parallel with samples of amplifed insulin-receptor DNA, the sequence of which was known to be normal. Second, the potential usefulness of the method as a large-scale screening approach was tested by studying 30 NIDDM subjects at a candidate region for insulin resistance, i.e., the tyrosine kinase domain of the insulin receptor. Exons in which SSCPs were detected were sequenced to determine the nucleotide change responsible.
RESEARCH DESIGN AND METHODS
Detection of known mutations/polymorphisms. Table 1 gives details of all mutants tested. For detection of known mutations, genomic DNA from four patients with insulin-receptor mutations (1 homozygous and 3 heterozygous) was used as the template for PCR reactions. In addition, genomic DNA from five subjects with silent polymorphic nucleotide substitutions (2 homozygous and 3 heterozygous) was studied (for the purposes of this study, a nucleotide change that alters the amino acid sequence is referred to as a mutation, whereas nucleotide changes that are silent are referred to as polymorphisms). Seven plasmid DNA constructs containing either cloned cDNA from patients with mutations/ polymorphisms or mutations generated by random PCR mutagenesis (16) or site-directed mutagenesis were also studied. All mutations were single-nucleotide substitutions except number 13, which had three contiguous nucleotide substitutions in the same fragment, and number 14, which had two single-nucleotide substitutions in adjacent codons. The primers used for amplification depended on the site of the mutation. For genomic DNA, they were located in introns flanking the exon of interest as described by Seino et al. (17) , and for plasmids, they were complementary to flanking cDNA sequences (Table 2 ).
To provide further evidence that SSCPs are inherited in an allelic fashion, five members (3 affected, 2 unaffected) of a family with a mutant transthyretin gene (ACC -» GCC at codon 109 in exon 4; 18) were studied in a similar fashion to primers that amplified exon 4. Screening of NIDDM population. Genomic DNA was extracted from 30 unrelated white British subjects with NIDDM. All subjects conformed to the entry criteria for the United Kingdom Prospective Study of Therapies of NIDDM (19) and 
The site and nature of each mutation/polymorphism are shown along with the source of template (DNA) for polymerase chain reaction (PCR), the size of the PCR-amplified DNA fragment subjected to SSCP analysis, and the primer set used for PCR (see Table 2 for primer sets A-C).
Order in which mutants were tested is indicated. Gel A, 5% polyacrylamide gels run at 4°C; gel B, 5% polyacrylamide/10% glycerol gels run at room temperature; + and -, presence or absence, respectively, of variant SSCP patterns detected with either electrophoresis condition. 
*lnsulin-receptor exon 17 primer set used to PCR amplify exclusively exon 17 without flanking intronic DNA.
gave informed consent to the study. Their DNA was PCR amplified with primers that amplified exons 17-21 of the insulin receptor, a region encompassing the tyrosine kinase domain.
Genomic DNA from 13 normoglycemic white control subjects was included in subsequent studies done with allelespecific oligonucleotide hybridization (ASO). All had fasting glucose <5.7 mM, normal HbA 1c (<6.1%), and no family history of diabetes. SSCP methods. PCR reactions were performed with primer pairs listed in Tables 1 and 2 with 100 ng genomic DNA or 1 ng plasmid DNA, 70 (xmol each dNTP, 0.5 jxmol each primer, 10 mM Tris-HCI (pH 8.3), 50 mM KCI, 0.25 U Thermus aquaticus DNA polymerase (Perkin-Elmer/Cetus, Norwalk, CT), and 1 |xCi of [a-32 P]dCTP (3000 Ci/mmol, 10 mCi/ml) in a final volume of 10 |xl. PCR was performed for 40 cycles at a denaturation temperature of 94°C for 30 s, annealing at 58°C for 1 min, and extension at 72°C for 2 min. One microliter of PCR product was visualized after electrophoresis in a 1.8% agarose minigel to confirm the absence of contamination in negative control samples and to ensure that the PCR product was a single band of the appropriate size. One microliter of each PCR product was added to 9 |xl of a solution of 95% formamide, 20 mM EDTA, and 0.05% bromophenol blue in 96-well microtiter plates. Immediately before electrophoresis, the samples were heated to 94°C for 2 min in a water bath. Two-microliter aliquots of each denatured sample were loaded onto two different 38 cm x 20 cm x 0.4-mm 5% polyacrylamide (49:1 ratio of acrylamide to bisacrylamide) gels, one with and one without 10% glycerol in addition to 90 mM Tris-borate (pH 8.3) and 2 mM EDTA. Electrophoresis of glycerol-containing gels was performed at room temperature at 25 W constant power. Gels without glycerol were run at 4°C at 50 W constant power. After electrophoresis, gels were transferred to Whatman 3M paper and dried on a vacuum slab gel dryer. Autoradiography with Kodak X-Omat film at -70°C without intensifying screens allowed detection of PCR products after 1-5 h of exposure. Direct sequencing. One hundred nanograms of genomic DNA was amplified with PCR as previously described (3). The PCR product was purified by agarose-gel electrophoresis and electroelution (3) . One hundred to 200 ng of PCR product was alkaline denatured, neutralized, and ethanol precipitated. The denatured double-stranded DNA template was sequenced with modified T7 DNA polymerase (Sequenase, United States Biochemical, Cleveland, OH) with a [7- 32 P]ATP end-labeled sequencing primer (either of the 2 PCR primers used to amplify the DNA fragment or internalsequencing primers) as we have described previously (3) . ASO. Fifty nanograms of each PCR product was alkaline denatured and applied to nitrocellulose filters with a slot-blot manifold (BRL). Slot blots were prehybridized (1 h)/hybridized (overnight) according to a modification of the method of Myerowitz (20) Filters were washed in 6 x SSC (0.9 M NaCI, 90 mM Na 3 C 6 H 5 O 7 ) and 0.1% sodium dodecyl sulfate twice at room temperature for 10 min, twice at 37°C for 10 min, and finally once at 55-60°C for 10 min.
RESULTS
Sensitivity and specificity of SSCP analysis. SSCP analysis had a high sensitivity (9 of 9) for detection of both heterozygous and homozygous nucleotide substitutions in various exons of the insulin-receptor gene. The amplified fragments in which point mutations were detected ranged in size from 285 to 322 bp (Table 1 ). Figure 1 shows several examples of the variant SSCP patterns seen in mutants versus controls. SSCP analysis distinguished between heterozygous, homozygous, and normal sequences in exon 7 of the insulin receptor. The three siblings with the mutant transthyretin allele were readily distinguishable from their unaffected siblings. Most mutations were detected in both gel-running conditions, but some were detectable only in one (Table 1) . Of the seven mutant plasmids, only five were detected by SSCP analysis. The two undetected mutants were single-nucleotide substitutions contained in 677-bp fragments. This is consistent with the estimated limit of sensitivity reported by Orita et al. (15) to be -4 0 0 bp. Plasmid 13, a triple mutant, was detected in a fragment of 597 bp. All possible types of mutations were not tested, but SSCP detected both transitions and transversions. No variant SSCP bands were detected in the control samples of normal sequence, implying high specificity. Detection of mutation in exon 18 of insulin receptor. The SSCP patterns for exons 19, 20 , and 21 were identical in all 30 NIDDM subjects under both gel-running conditions (Fig.  2) . In exon 18, 1 subject had a variant SSCP pattern most viduals with each of the SSCP patterns A, B, and C and 1 individual each with patterns D and E was subjected to direct DNA sequencing compared with known normal subjects. Three single-nucleotide substitutions were found-two common silent polymorphisms at positions 984 (TAC-* TAT) and 1058 (CAC -> CAT, silent). The subject with SSCP pattern E had a GTG -*• ATG mutation at codon 985, which results in a Val -> Met amino acid substitution. The five SSCP patterns were explicable by combinations of these nucleotide substitutions (Fig. 4) . ASO hybridization of the diabetic and control populations for the Met 985 mutation confirmed its presence in heterozygous form in the relevant diabetic subject and in 1 of 13 control subjects. easily seen in the 10% glycerol gel. Direct sequencing of this subject's exon 18 revealed a heterozygous point mutation in codon 1068 (AAG -» GAG), which results in the substitution of the acidic amino acid glutamic acid for the basic residue lysine.
ASO confirmed that this subject's exon 18 contained both mutant and wild-type sequences (Fig. 3) and that only wildtype sequence was present in the other 29 diabetic subjects. This mutation was not detected in 13 nondiabetic subjects. Detection of polymorphisms and mutation in exon 17. Five different SSCP patterns were detected in PCR-amplified exon 17 (Fig. 4) . Sixteen subjects had pattern C, 9 pattern B, 3 pattern A, and 1 each had patterns D and E. To exclude the possibility that this marked variability was due to highly variant intronic sequences in the short stretches of DNA between the primers and the exons, the subjects' DNA was reamplified with a second set of exon 17 primers designed to amplify exonic sequences only (Table 2) . Again, five SSCP patterns were detected, which corresponded exactly to the previous results, suggesting that any nucleotide changes were restricted to coding sequences. Exon 17 from 2 indi-
DISCUSSION
We demonstrated that SSCP analysis is a sensitive specific tool for the detection of mutations in the insulin-receptor gene and, using this technique, have detected two novel mutations in a highly conserved region of the insulin receptor in patients with NIDDM. The findings that these variant receptors are uncommon and that one of them ( in a normoglycemic subject do not exclude a possible pathogenic role for these mutations in the development of diabetes, because the genetic basis of NIDDM is likely to be complex and to involve the interaction of genetic defects impairing both insulin sensitivity and secretion (21) . Both Val 985 and Lys 1068 are located within the highly conserved tyrosine kinase domain of the receptor and are conserved in the insulin receptor of other mammalian species (22, 23) . The Lys 1068 mutation results in the replacement of a basic residue by a highly acidic one, an alteration that is unlikely to be biologically silent. Although the Val 985 -* Met 985 mutation is a relatively conservative substitution, Val is also conserved in all known mammalian insulin receptors, the insulinlike growth factor I receptor (24) , and the recently cloned insulin-receptor-related protein (25) . Changes in secondary structure and thus biological activity could potentially result from this genetic variant. The investigation of candidate genes in NIDDM has, to date, largely been restricted to studies of the association of restriction-fragment-length polymorphisms with the disease in populations or families. The results of these studies at the insulin-receptor locus have been conflicting but certainly do not exclude a contributory role of insulin-receptor gene defects in some patients (6, 7) . Because complete nucleotide sequencing of the insulin-receptor gene is a laborious task, it has been undertaken in only a few NIDDM subjects, in all of whom the sequence was normal.
Other candidate genes more amenable to sequencing because of their smaller size have been studied in subjects with NIDDM. Nucleotide sequencing of the insulin gene (26) and the islet amyloid polypeptide gene (27) in groups of NIDDM subjects has not revealed any variant sequences, although some subjects studied because of the finding of marked hyperinsulinemia have been found to have insulin gene mutations (28) . Therefore, the two insulin-receptor gene mutations described above are the first potentially significant mutations in candidate genes to be found by screening otherwise unselected patients with NIDDM.
The SSCP technique should have wide applicability to the study of other candidate genes in NIDDM and various additional disorders. Some technical aspects of SSCP analysis are therefore worth discussion. Our findings suggest that the sensitivity of the technique can be increased by subjecting amplified products to electrophoresis under at least two different conditions, in contrast to Orita et al. (15) , who reported obtaining maximal sensitivity with gels containing 10% glycerol run at room temperature. The three mutations that were more easily detected in the glycerol-free gels were all T -» C transitions. Definite conclusions regarding the optimal conditions for detection of each type of mutation would require study of a larger sample of mutants. Our results also demonstrate that it is possible to detect differences in SSCP patterns between heterozygous and homozygous mutations. The detection of two point mutations in fragments >450 bp suggests that the previously reported size limit for the technique may be an underestimate (15) .
Of further interest is the fact that each of the three polymorphisms/mutations detected in exon 17 occurs at a CG dinucleotide. In the low-density lipoprotein-receptor locus, it has been found that, where CG dinucleotides are sites of frequent mutation, the cytosine is invariably methylated (29) . This has led to the concept of methylcytosine acting as an endogenous mutagen (29) . The clustering of CG residues, which are prone to mutation, in exon 17 suggests that this exon of the insulin receptor may also be extensively methylated in human DNA.
We conclude that the technique of SSCP analysis is a sensitive and specific tool for the detection of insulin-recep-tor genetic variants. The detection of novel and potentially biologically significant mutations in the tyrosine kinase domain of the receptor patients with "conventional" NIDDM is of interest. Definitive conclusions regarding the contribution of these mutations to the pathogenesis of diabetes in these individuals and others will require further studies, including assessment of the frequency of the mutations in large numbers of diabetic and nondiabetic subjects from different racial groups, in vivo and in vitro studies of insulin sensitivity in individuals possessing these insulin-receptor variants, and examination of the signaling properties of the expressed mutant receptors.
